According to scientists, clinical trials of
experimental treatment for Parkinson’s disease could not substantially prove whether
the treatment was able to halt or slow down the disease. The treatment is called
Glial Cell Line Derived Neurotrophic Factor (GDNF). GDNF is made by
privately-held Canadian biotech firm MedGenesis Therapeutix.
Clinical trials are scientific studies
conducted to find better ways to prevent, screen for, diagnose, or treat
disease. Clinical trials study
how safe and helpful tests and treatments are.
Parkinson’s is a neurodegenerative disease. Parkinson’s
disease affects the nerve cells in the brain that produce dopamine. It causes
tremors, muscle stiffness and movement and balance problems. Although some
medicines can improve symptoms, there is no cure or treatment that can slow
progression of the disease. The disease affects around 1% to 2% of people over